U.S. markets closed

Evofem Biosciences, Inc. (EVFM)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.8377+0.0247 (+3.04%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 9/18/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 7

Trading Information

Stock Price History

Beta (5Y Monthly) -0.48
52-Week Change 3-64.19%
S&P500 52-Week Change 335.11%
52 Week High 35.5300
52 Week Low 30.6540
50-Day Moving Average 30.7968
200-Day Moving Average 31.3050

Share Statistics

Avg Vol (3 month) 35.02M
Avg Vol (10 day) 32.52M
Shares Outstanding 5155.21M
Implied Shares Outstanding 6N/A
Float 142.83M
% Held by Insiders 11.35%
% Held by Institutions 129.88%
Shares Short (Aug 30, 2021) 426.88M
Short Ratio (Aug 30, 2021) 45.06
Short % of Float (Aug 30, 2021) 419.19%
Short % of Shares Outstanding (Aug 30, 2021) 417.32%
Shares Short (prior month Jul 29, 2021) 428.24M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jan 17, 2018
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Jun 29, 2021


Profit Margin 0.00%
Operating Margin (ttm)-4,340.43%

Management Effectiveness

Return on Assets (ttm)-75.84%
Return on Equity (ttm)-387.27%

Income Statement

Revenue (ttm)3.41M
Revenue Per Share (ttm)0.04
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)78k
EBITDA -147.27M
Net Income Avi to Common (ttm)-150.07M
Diluted EPS (ttm)-1.6220
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)46.98M
Total Cash Per Share (mrq)0.3
Total Debt (mrq)78.14M
Total Debt/Equity (mrq)871.75
Current Ratio (mrq)1.40
Book Value Per Share (mrq)0.06

Cash Flow Statement

Operating Cash Flow (ttm)-162.94M
Levered Free Cash Flow (ttm)-128.71M